Tag: Immunotherapy

Filter

Thought Leadership

Product

Community

NantHealth
NantHealth Presented Clinical Data on Immunotherapy, Molecularly Targeted Agents and Tumor Biology at the American Society of Clinical Oncology (ASCO)...
Findings presented during the developmental therapeutics session at the ASCO 2020 Virtual Scientific Program Culver City, CA – June 18,...
NantHealth
Precision Insights
NantCell Announces New Celgene Investment
Immunotherapy Company Will Present Findings at the JP Morgan Healthcare Conference in San Francisco on January 7th Second Round Crossover Funding...
Precision Insights
NantHealth
NantHealth Announces Immunotherapy Clinical Trials in the Mid-Atlantic, First Whole Genomics Supercomputing Medical Reasoning Engine Helps Oncologists Make Informed Treatment...
Horizon Blue Cross Blue Shield, New Jersey’s largest health insurance plan, to reimburse for GPS CancerTM comprehensive molecular test in investigational...
NantHealth
Precision Insights
Precision Biologics, a NantWorks Company, to Present Combination Immunotherapy of a Novel Neo-Epitope Antibody Targeting Ovarian and Uterine Cancer at...
Positive preclinical data on a novel human monoclonal antibody that specifically targets ovarian and uterine cancer subtypes and demonstration of...
Precision Insights
NantHealth
Historic National Coalition Formed to Accelerate Next Generation Immunotherapy in Cancer
January 7, 2016 Large Pharma, Biotech, Major Payer, Fortune 50 Company, Academia and Community Oncologists Join Forces to Announce Launch...
NantHealth

NantHealth | Technology that Simplifies Healthcare.